{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:35:20Z","timestamp":1791920120648,"version":"4.3.4"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100005089","name":"Beijing Municipal Natural Science Foundation","doi-asserted-by":"publisher","award":["7182113"],"award-info":[{"award-number":["7182113"]}],"id":[{"id":"10.13039\/501100005089","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2016YFC1000905"],"award-info":[{"award-number":["2016YFC1000905"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013076","name":"National Major Science and Technology Projects of China","doi-asserted-by":"publisher","award":["2018ZX09711001-009-009"],"award-info":[{"award-number":["2018ZX09711001-009-009"]}],"id":[{"id":"10.13039\/501100013076","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003345","name":"Chinese Academy of Meteorological Sciences","doi-asserted-by":"publisher","award":["2016-I2M-3-007"],"award-info":[{"award-number":["2016-I2M-3-007"]}],"id":[{"id":"10.13039\/501100003345","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.intimp.2021.107507","type":"journal-article","created":{"date-parts":[[2021,2,28]],"date-time":"2021-02-28T18:09:23Z","timestamp":1614535763000},"page":"107507","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"special_numbering":"C","title":["Inhibition of hypoxia inducible factor 1 by YC-1 attenuates tissue plasminogen activator induced hemorrhagic transformation by suppressing HMGB1\/TLR4\/NF-\u03baB mediated neutrophil infiltration in thromboembolic stroke rats"],"prefix":"10.1016","volume":"94","author":[{"given":"Linglei","family":"Kong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinzhong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nannan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guodong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengdi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruili","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanhua","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2021.107507_b0005","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/jcbfm.2013.203","article-title":"Hemorrhagic transformation after ischemic stroke in animals and humans","volume":"34","author":"Jickling","year":"2014","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.intimp.2021.107507_b0010","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S1474-4422(13)70055-3","article-title":"Factors influencing haemorrhagic transformation in ischaemic stroke","volume":"12","author":"\u00c1lvarez-Sab\u00edn","year":"2013","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.intimp.2021.107507_b0015","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1007\/s12035-014-8952-x","article-title":"Hemorrhagic transformation after tissue plasminogen activator reperfusion therapy for ischemic stroke: mechanisms, models, and biomarkers","volume":"52","author":"Wang","year":"2015","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.intimp.2021.107507_b0020","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3389\/fncel.2016.00002","article-title":"A review of the mechanisms of blood-brain barrier permeability by tissue-type plasminogen activator treatment for cerebral ischemia","volume":"10","author":"Suzuki","year":"2016","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.intimp.2021.107507_b0025","doi-asserted-by":"crossref","first-page":"e343","DOI":"10.1161\/STR.0000000000000152","article-title":"Treatment and outcome of hemorrhagic transformation after intravenous alteplase in acute ischemic stroke: a scientific statement for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"48","author":"Yaghi","year":"2017","journal-title":"Stroke"},{"key":"10.1016\/j.intimp.2021.107507_b0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.107216","article-title":"Neuroinflammation in hemorrhagic transformation after tissue plasminogen activator thrombolysis: potential mechanisms, targets, therapeutic drugs and biomarkers","volume":"90","author":"Ma","year":"2021","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2021.107507_b0035","first-page":"395","article-title":"The plasminogen activation system in neuroinflammation","volume":"1862","author":"Mehra","year":"2016","journal-title":"BBA"},{"key":"10.1016\/j.intimp.2021.107507_b0040","doi-asserted-by":"crossref","first-page":"240","DOI":"10.5551\/jat.RV16006","article-title":"Therapeutic strategies to attenuate hemorrhagic transformation after tissue plasminogen activator treatment for acute ischemic stroke","volume":"24","author":"Kanazawa","year":"2017","journal-title":"J Atheroscler Thromb"},{"key":"10.1016\/j.intimp.2021.107507_b0045","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s10571-012-9803-9","article-title":"Hypoxia inducible factor-1: its potential role in cerebral ischemia","volume":"32","author":"Singh","year":"2012","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.intimp.2021.107507_b0050","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1089\/ham.2012.1052","article-title":"HIF-1 at the blood-brain barrier: a mediator of permeability?","volume":"13","author":"Ogunshola","year":"2012","journal-title":"High Alt. Med. Biol."},{"key":"10.1016\/j.intimp.2021.107507_b0055","first-page":"2689","article-title":"Acetylpuerarin inhibits oxygen-glucose deprivation-induced neuroinflammation of rat primary astrocytes via the suppression of HIF-1 signaling","volume":"16","author":"Xiang","year":"2018","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.intimp.2021.107507_b0060","doi-asserted-by":"crossref","first-page":"6340","DOI":"10.1038\/ncomms7340","article-title":"The HIF-1\/glial TIM-3 axis controls inflammation-associated brain damage under hypoxia","volume":"6","author":"Koh","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2021.107507_b0065","first-page":"7730","article-title":"Isoflurane\u2013induced postoperative cognitive dysfunction is mediated by hypoxia\u2013inducible factor\u20131\u03b1\u2013dependent neuroinflammation in aged rats","volume":"17","author":"Cao","year":"2018","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.intimp.2021.107507_b0070","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1742-2094-4-12","article-title":"Hypoxia-inducible factor-1 (HIF-1) is involved in the regulation of hypoxia-stimulated expression of monocyte chemoattractant protein-1 (MCP-1\/CCL2) and MCP-5 (Ccl12) in astrocytes","volume":"4","author":"Mojsilovic-Petrovic","year":"2007","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.intimp.2021.107507_b0075","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/jcbfm.2013.163","article-title":"Progesterone attenuates hemorrhagic transformation after delayed tPA treatment in an experimental model of stroke in rats: involvement of the VEGF-MMP pathway","volume":"34","author":"Won","year":"2014","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.intimp.2021.107507_b0080","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1161\/STROKEAHA.110.586198","article-title":"Erythropoietin in combination of tissue plasminogen activator exacerbates brain hemorrhage when treatment is initiated 6 hours after stroke","volume":"41","author":"Jia","year":"2010","journal-title":"Stroke"},{"key":"10.1016\/j.intimp.2021.107507_b0085","first-page":"255","article-title":"A domain responsible for HIF-1alpha degradation by YC-1, a novel anticancer agent","volume":"29","author":"Kim","year":"2006","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.intimp.2021.107507_b0090","doi-asserted-by":"crossref","first-page":"3729","DOI":"10.1158\/1535-7163.MCT-08-0074","article-title":"A novel mode of action of YC-1 in HIF inhibition: stimulation of FIH-dependent p300 dissociation from HIF-1{alpha}","volume":"7","author":"Li","year":"2008","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.intimp.2021.107507_b0095","doi-asserted-by":"crossref","first-page":"3941","DOI":"10.1038\/sj.onc.1210169","article-title":"YC-1 inhibits HIF-1 expression in prostate cancer cells: contribution of Akt\/NF-kappaB signaling to HIF-1alpha accumulation during hypoxia","volume":"26","author":"Sun","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.intimp.2021.107507_b0100","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/S0006-2952(01)00564-0","article-title":"Inhibitory effect of YC-1 on the hypoxic induction of erythropoietin and vascular endothelial growth factor in Hep3B cells","volume":"61","author":"Chun","year":"2001","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.intimp.2021.107507_b0105","doi-asserted-by":"crossref","first-page":"257","DOI":"10.3389\/fnmol.2017.00257","article-title":"\u03b22-Adrenergic receptor-mediated HIF-1\u03b1 upregulation mediates blood brain barrier damage in acute cerebral ischemia","volume":"10","author":"Sun","year":"2017","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.intimp.2021.107507_b0110","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1124\/mol.107.036418","article-title":"Inhibition of hypoxia-induced increase of blood-brain barrier permeability by YC-1 through the antagonism of HIF-1alpha accumulation and VEGF expression","volume":"72","author":"Yeh","year":"2007","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.intimp.2021.107507_b0115","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jns.2015.09.362","article-title":"A novel embolic middle cerebral artery occlusion model induced by thrombus formed in common carotid artery in rat","volume":"359","author":"Ma","year":"2015","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.intimp.2021.107507_b0120","doi-asserted-by":"crossref","first-page":"8943210","DOI":"10.1155\/2018\/8943210","article-title":"Pinocembrin protects blood\u2013brain barrier function and expands the therapeutic time window for tissue-type plasminogen activator treatment in a rat thromboembolic stroke model","volume":"2018","author":"Ma","year":"2018","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.intimp.2021.107507_b0125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0027798","article-title":"Differential effects of HIF-1 inhibition by YC-1 on the overall outcome and blood-brain barrier damage in a rat model of ischemic stroke","volume":"6","author":"Yan","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.intimp.2021.107507_b0130","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/1742-2094-11-112","article-title":"Neutralization of chemokine-like factor 1, a novel C-C chemokine, protects against focal cerebral ischemia by inhibiting neutrophil infiltration via MAPK pathways in rats","volume":"11","author":"Kong","year":"2014","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.intimp.2021.107507_b0135","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1161\/STROKEAHA.114.005116","article-title":"Delayed hyperbaric oxygen therapy promotes neurogenesis through reactive oxygen species\/hypoxia-inducible factor-1\u03b1\/\u03b2-catenin pathway in middle cerebral artery occlusion rats","volume":"45","author":"Hu","year":"2014","journal-title":"Stroke"},{"key":"10.1016\/j.intimp.2021.107507_b0140","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1111\/bph.12489","article-title":"Cell-specific blood-brain barrier regulation in health and disease: a focus on hypoxia","volume":"171","author":"Engelhardt","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.intimp.2021.107507_b0145","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1177\/0271678X15624933","article-title":"Neuronal HIF-1\u03b1 and HIF-2\u03b1 deficiency improves neuronal survival and sensorimotor function in the early acute phase after ischemic stroke","volume":"37","author":"Barteczek","year":"2017","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.intimp.2021.107507_b0150","doi-asserted-by":"crossref","first-page":"E278","DOI":"10.1152\/ajpendo.00129.2014","article-title":"Tissue-type plasminogen activator deficiency delays bone repair: roles of osteoblastic proliferation and vascular endothelial growth factor","volume":"307","author":"Kawao","year":"2014","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.intimp.2021.107507_b0155","doi-asserted-by":"crossref","first-page":"9848","DOI":"10.1523\/JNEUROSCI.1241-12.2012","article-title":"Tissue-type plasminogen activator regulates the neuronal uptake of glucose in the ischemic brain","volume":"32","author":"Wu","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.intimp.2021.107507_b0160","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.brainresrev.2009.09.006","article-title":"The role and regulation of hypoxia-inducible factor 1alpha expression in brain development and neonatal hypoxic-ischemic brain injury","volume":"62","author":"Fan","year":"2009","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.intimp.2021.107507_b0165","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1002\/glia.23109","article-title":"Hypoxia-independent mechanisms of HIF-1\u03b1 expression in astrocytes after ischemic preconditioning","volume":"65","author":"Hirayama","year":"2017","journal-title":"Glia"},{"key":"10.1016\/j.intimp.2021.107507_b0170","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.nbd.2008.05.020","article-title":"HIF-1alpha inhibition ameliorates neonatal brain injury in a rat pup hypoxic-ischemic model","volume":"31","author":"Chen","year":"2008","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.intimp.2021.107507_b0175","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1097\/01.WCB.0000137868.50767.E8","article-title":"The neurotoxicity of tissue plasminogen activator?","volume":"24","author":"Kaur","year":"2004","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.intimp.2021.107507_b0180","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1038\/nn1757","article-title":"Neutralizing the neurotoxic effects of exogenous and endogenous tPA","volume":"9","author":"Armstead","year":"2006","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.intimp.2021.107507_b0185","doi-asserted-by":"crossref","first-page":"3372","DOI":"10.1161\/STROKEAHA.108.514026","article-title":"Extension of the thrombolytic time window with minocycline in experimental stroke","volume":"39","author":"Murata","year":"2008","journal-title":"Stroke"},{"key":"10.1016\/j.intimp.2021.107507_b0190","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1038\/jcbfm.2011.9","article-title":"Inhibition of VEGF signaling pathway attenuates hemorrhage after tPA treatment","volume":"31","author":"Kanazawa","year":"2011","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.intimp.2021.107507_b0195","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1182\/blood-2016-09-740670","article-title":"Plasma kallikrein mediates brain hemorrhage and edema caused by tissue plasminogen activator therapy in mice after stroke","volume":"129","author":"Sim\u00e3o","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2021.107507_b0200","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1002\/jcp.24544","article-title":"Hypoxia selectively disrupts brain microvascular endothelial tight junction complexes through a hypoxia-inducible factor-1 (HIF-1) dependent mechanism","volume":"229","author":"Engelhardt","year":"2014","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.intimp.2021.107507_b0205","first-page":"6490","article-title":"Therapeutic window for YC 1 following glutamate induced neuronal damage and transient focal cerebral ischemia","volume":"17","author":"Tai","year":"2018","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.intimp.2021.107507_b0210","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1002\/jnr.22361","article-title":"Suppression of hypoxia-inducible factor-1alpha and its downstream genes reduces acute hyperglycemia-enhanced hemorrhagic transformation in a rat model of cerebral ischemia","volume":"88","author":"Chen","year":"2010","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.intimp.2021.107507_b0215","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.nbd.2010.03.008","article-title":"Molecular insights and therapeutic targets for blood-brain barrier disruption in ischemic stroke: critical role of matrix metalloproteinases and tissue-type plasminogen activator","volume":"38","author":"Jin","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.intimp.2021.107507_b0220","doi-asserted-by":"crossref","first-page":"32","DOI":"10.3389\/fneur.2013.00032","article-title":"Matrix metalloproteinases and blood-brain barrier disruption in acute ischemic stroke","volume":"4","author":"Lakhan","year":"2013","journal-title":"Front. Neurol."},{"key":"10.1016\/j.intimp.2021.107507_b0225","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1161\/hs0302.104542","article-title":"Involvement of matrix metalloproteinase in thrombolysis associated hemorrhagic transformation after embolic focal ischemia in rats","volume":"33","author":"Sumii","year":"2002","journal-title":"Stroke"},{"key":"10.1016\/j.intimp.2021.107507_b0230","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1111\/j.1538-7836.2007.02628.x","article-title":"Stromelysin-1 (MMP-3) is critical for intracranial bleeding after t-PA treatment of stroke in mice","volume":"5","author":"Suzuki","year":"2007","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.intimp.2021.107507_b0235","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.expneurol.2013.03.019","article-title":"Hyperbaric oxygen preconditioning attenuates hyperglycemia-enhanced hemorrhagic transformation by inhibiting matrix metalloproteinases in focal cerebral ischemia in rats","volume":"247","author":"Soejima","year":"2013","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.intimp.2021.107507_b0240","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3389\/fncel.2016.00056","article-title":"Implications of MMP9 for blood brain barrier disruption and hemorrhagic transformation following ischemic stroke","volume":"10","author":"Turner","year":"2016","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.intimp.2021.107507_b0245","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1161\/STROKEAHA.115.011238","article-title":"Thromboinflammation in stroke brain damage","volume":"47","author":"De Meyer","year":"2016","journal-title":"Stroke"},{"key":"10.1016\/j.intimp.2021.107507_b0250","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.pharmthera.2018.09.005","article-title":"Neutrophils in tPA-induced hemorrhagic transformations: main culprit, accomplice or innocent bystander?","volume":"194","author":"Ouk","year":"2019","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.intimp.2021.107507_b0255","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.vph.2014.11.007","article-title":"Treatment with recombinant tissue plasminogen activator (r-TPA) induces neutrophil degranulation in vitro via defined pathways","volume":"64","author":"Carbone","year":"2015","journal-title":"Vasc. Pharmacol."},{"key":"10.1016\/j.intimp.2021.107507_b0260","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1189\/jlb.0907606","article-title":"Tissue plasminogen activator (t-PA) promotes neutrophil degranulation and MMP-9 release","volume":"84","author":"Cuadrado","year":"2008","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.intimp.2021.107507_b0265","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/ene.13575","article-title":"Increase in neutrophils after recombinant tissue plasminogen activator thrombolysis predicts poor functional outcome of ischaemic stroke: a longitudinal study","volume":"25","author":"Shi","year":"2018","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.intimp.2021.107507_b0270","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1186\/s12974-016-0680-x","article-title":"Dynamic change of neutrophil to lymphocyte ratio and hemorrhagic transformation after thrombolysis in stroke","volume":"13","author":"Guo","year":"2016","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.intimp.2021.107507_b0275","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/j.1476-5381.2009.00068.x","article-title":"Neutrophils contribute to intracerebral haemorrhages after treatment with recombinant tissue plasminogen activator following cerebral ischaemia","volume":"156","author":"Gautier","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.intimp.2021.107507_b0280","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1742-2094-10-27","article-title":"Toll-like receptor 4 signaling in intracerebral hemorrhage-induced inflammation and injury","volume":"10","author":"Fang","year":"2013","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.intimp.2021.107507_b0285","doi-asserted-by":"crossref","first-page":"37773","DOI":"10.18632\/oncotarget.9329","article-title":"Crosstalk between the HIF-1 and Toll-like receptor\/nuclear factor-\u03baB pathways in the oral squamous cell carcinoma microenvironment","volume":"7","author":"Han","year":"2016","journal-title":"Oncotarget"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576921001430?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576921001430?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T17:27:26Z","timestamp":1761586046000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576921001430"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":57,"alternative-id":["S1567576921001430"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2021.107507","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of hypoxia inducible factor 1 by YC-1 attenuates tissue plasminogen activator induced hemorrhagic transformation by suppressing HMGB1\/TLR4\/NF-\u03baB mediated neutrophil infiltration in thromboembolic stroke rats","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2021.107507","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"107507"}}